drugset / Trial / NCT03529149

TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVT

NCT03529149

Phase 4 Unknown 90 enrolled Xuanwu Hospital, Beijing
RandomizedCrossoverOpen-labelTreatment

Summary

Investigators hypothesized that the precise regulation of blood pressure based on the changes of cerebral blood flow parameters under TCD monitoring can better improve the state of cerebral blood flow, reduce the risk of early neurological deterioration and improve the prognosis of the patients.

Timeline

Start
2018-04-08
Primary completion
2019-06-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Background Urapidil Small molecule Intravenous

Indications